Ambeed.cn

首页 / / / / 9-Aminocamptothecin

9-氨基喜树碱 /9-Aminocamptothecin {[allProObj[0].p_purity_real_show]}

货号:A432426 同义名: 9-Amino-20(S)-camptothecin;9-Amino-CPT

9-Aminocamptothecin, a natural product isolated and purified from the barks of Camptotheca acuminata Decne, is an active derivative of camptothecin, which belongs to the general group of chemotherapy drugs called topoisomerase inhibitors. 9-Aminocamptothecin is an inhibitor of Topo I.

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
9-Aminocamptothecin 化学结构 CAS号:91421-43-1
9-Aminocamptothecin 化学结构
CAS号:91421-43-1
9-Aminocamptothecin 3D分子结构
CAS号:91421-43-1
9-Aminocamptothecin 化学结构 CAS号:91421-43-1
9-Aminocamptothecin 3D分子结构 CAS号:91421-43-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

9-Aminocamptothecin 纯度/质量文件 产品仅供科研

货号:A432426 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >
产品名称 Topo I Topo II Topo IV Topoisomerase 其他靶点 纯度
Ellagic acid 98%
β-Lapachone 99%+
(s)-10-hydroxycamptothecin 98+%
Camptothecin ++

Topo I, IC50: 0.68 μM

98%
Betulinic acid ++

Eukaryotic topoisomerase I, IC50: 5 μM

98%
Topotecan ++++

Topo I (MCF-7 Luc cells), IC50: 13 nM

Topo I (DU-145 Luc cells), IC50: 2 nM

98%
Irinotecan HCl Trihydrate 98%
SN-38 98%
Levofloxacin hydrate 98%
Dexrazoxane 99%+
Ofloxacin 98+%
Enoxacin 99%+
Flumequine +

Topo II, IC50: 15 μM

98%
Levofloxacin 97%
Etoposide 98%
Pefloxacin mesylate dihydrate 99+%
Marbofloxacin 98+%
Voreloxin HCl 98%
Mitoxantrone dihydrochloride PKC 98%
Nalidixic acid 98%
Doxorubicin 98%
Novobiocin sodium 95%
Amonafide 99%+
Pirarubicin 98%+
Idarubicin HCl +++

Topo II (MCF-7 cells), IC50: 3.3 ng/mL

99%+
Genistein EGFR 98%
Teniposide 98%
Moxifloxacin 98%
Ciprofloxacin 98%
Clinafloxacin 97%
Gatifloxacin 98%
Daunorubicin HCl +++

DNA synthesis, Ki: 20 nM

98%
Epirubicin HCl 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

9-Aminocamptothecin 生物活性

描述 9-Aminocamptothecin, an inhibitor of topoisomerase I, exhibits strong anticancer properties. In cancer cell lines from such as breast (MCF-7), bladder (MGH-U1), and colon (HT-29), the cytotoxic effects of 9-Aminocamptothecin escalate with increased drug concentrations and prolonged exposure periods. Notably, minimal cell death occurs unless the concentration of 9-Aminocamptothecin surpasses a threshold of 2.7 nM[1]. 9-Aminocamptothecin demonstrates inhibition of PC-3, PC-3M, DU145, and LNCaP cells, with IC50 values of 34.1 nM, 10 nM, 6.5 nM, and 8.9 nM respectively, following a drug exposure period of 96 hours[2].

9-Aminocamptothecin 动物研究

Animal study 9-Aminocamptothecin (9-Amino-CPT) curtails tumor growth at the minimal oral dosage of 0.35 mg/kg/day, while higher oral dosages of 0.75 and 1 mg/kg/day and subcutaneous administration at 4 mg/kg/week lead to tumor regression. The compound is well-tolerated across all dosages, with no instances of toxic death or weight loss exceeding 10% in any treatment group[2]. 9-Aminocamptothecin leads to complete remissions in 55% of SCID mice implanted with human myeloid leukemia. Both oral and intravenous administration methods prove to be equally efficacious. These findings from the pre-clinical model advocate for the assessment of 9-Aminocamptothecin as an antileukemic agent in a phase I clinical trial for patients with AML[3].

9-Aminocamptothecin 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00003551 Kidney Cancer Phase 2 Completed - United States, Georgia ... 展开 >> Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 Emory University School of Medicine Atlanta, Georgia, United States, 30322 收起 <<
NCT00003523 Ovarian Cancer ... 展开 >> Primary Peritoneal Cavity Cancer 收起 << Phase 2 Completed - -
NCT00002635 Lymphoma Phase 2 Completed - United States, Connecticut ... 展开 >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts New England Medical Center Hospital Boston, Massachusetts, United States, 02111 收起 <<

9-Aminocamptothecin 参考文献

[1]Li ML, et al. Pharmacological determinants of 9-aminocamptothecin cytotoxicity. Clin Cancer Res. 2001 Jan;7(1):168-74.

[2]de Souza PL, et al. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer. Clin Cancer Res. 1997 Feb;3(2):287-94.

[3]Jeha S, et al. Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia. Leuk Lymphoma. 1998 Dec;32(1-2):159-64.

9-Aminocamptothecin 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.75mL

0.55mL

0.28mL

13.76mL

2.75mL

1.38mL

27.52mL

5.50mL

2.75mL

9-Aminocamptothecin 技术信息

CAS号91421-43-1
分子式C20H17N3O4
分子量 363.367
别名 9-Amino-20(S)-camptothecin;9-Amino-CPT;NSC 603071;Aminocamptothecin;9-AC
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,Room Temperature

溶解度

DMSO: 3 mg/mL(8.26 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。